{
  "actions": [
    {
      "acted_at": "2014-12-08", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2014-12-08", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2014-12-12", 
      "action_code": "", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr5805-113", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "113", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2014-12-08", 
  "number": "5805", 
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to expanding access for breakthrough drugs, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Andrea Sloan Compassionate Use Reform and Enhancement Act", 
  "sponsor": {
    "bioguide_id": "M001157", 
    "district": "10", 
    "name": "McCaul, Michael T.", 
    "state": "TX", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2014-12-08", 
  "subjects": [
    "Administrative law and regulatory procedures", 
    "Administrative remedies", 
    "Advisory bodies", 
    "Congressional oversight", 
    "Consumer affairs", 
    "Department of Health and Human Services", 
    "Drug safety, medical device, and laboratory regulation", 
    "Drug therapy", 
    "Executive agency funding and structure", 
    "Food and Drug Administration (FDA)", 
    "Government information and archives", 
    "Government studies and investigations", 
    "Health", 
    "Health care coverage and access"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2014-12-08T05:00:00Z", 
    "text": "Andrea Sloan Compassionate Use Reform and Enhancement Act or the Andrea Sloan CURE Act - Amends the Federal Food, Drug, and Cosmetic Act to require the sponsor of a \u201cbreakthrough drug\u201d (which is a drug that qualifies for expedited approval, is an infectious disease product, or qualifies the sponsor for a priority review voucher) to submit to the Secretary of Health and Human Services (HHS) and make available to the public a policy on requests for access to the drug for compassionate use, including the minimum criteria for consideration or approval of requests and the time needed to make a decision.\n\nRequires a breakthrough drug sponsor to explain a denied request for compassionate use to the person who made the request.\n\nDirects HHS to establish an Expanded Access Task Force. Requires the Task Force and the Government Accountability Office (GAO) to evaluate patient access to investigational drugs and make recommendations for improving access.\n\nDirects HHS to finalize the draft guidance entitled \u201cExpanded Access to Investigational Drugs for Treatment Use--Qs & As,\u201d taking into account reports from the Task Force and GAO."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Andrea Sloan Compassionate Use Reform and Enhancement Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Andrea Sloan CURE Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to expanding access for breakthrough drugs, and for other purposes.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Andrea Sloan CURE Act", 
      "type": "display"
    }
  ], 
  "updated_at": "2016-10-25T16:17:38Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/113/hr/BILLSTATUS-113hr5805.xml"
}